In the last five years, the team responsible for running Grifols has changed more significantly than in the previous 100. Especially because it has not been until these new 20s that the blood products company has begun to delegate virtually all business decisions to professionals who are neither part of the founding family of the pharmaceutical company, nor of its close circle.
In the last five years, the team responsible for running Grifols has changed more significantly than in the previous 100. Especially because it has not been until these new 20s that the blood products company has begun to delegate virtually all business decisions to professionals who are neither part of the founding family of the pharmaceutical company, nor of its close circle.